Integra LifeSciences Holdings Corporation (IART)
NASDAQ
Closed
Oct 19, 2026
Day's Range
13.1152 wk Range
8.70Overview - IART - Integra LifeSciences Holdings Corporation
Key Statistics
Valuation
Enterprise Value
2.78B
P/E (Trailing)
‪66.48‬
P/E (Forward)
‪5.19‬
PEG Ratio
‪-0.65‬
Price / Sales (TTM)
‪0.63‬
Price / Book
‪1.00‬
EV / EBITDA
‪8.79‬
Profitability
Gross Margin
‪52.47%‬
Profit Margin
‪-0.44%‬
Operating Margin
‪9.62%‬
Return on Assets
‪2.82%‬
Return on Equity
‪-0.69%‬
Ownership
Shares Outstanding
77.77M
Float
58.65M
Short % of Shares Outstanding
‪12.06%‬
Held by Insiders
‪14.33%‬
Held by Institutions
‪98.69%‬
Price stats
Beta
‪1.21‬
50-Day Avg
‪16.22‬
200-Day Avg
‪14.06‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
11 analysts
Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - IART - Integra LifeSciences Holdings Corporation
Peers - IART - Integra LifeSciences Holdings Corporation
Peer Comparison
Compared with companies in Medical Devices listed on NASDAQ.
- IARTNASDAQIntegra LifeSciences Holdings Corporation1.04BMarket Cap-1.34%52-week change66.48P/E (Trailing)‪-0.44%‬Profit Margin
- DXCMNASDAQDexCom Inc.32.44BMarket Cap+18.88%52-week change34.14P/E (Trailing)‪20.11%‬Profit Margin
- GEHCNASDAQGE HealthCare Technologies Inc.31.64BMarket Cap-8.49%52-week change15.81P/E (Trailing)‪9.33%‬Profit Margin
- PODDNASDAQInsulet Corporation9.78BMarket Cap-131.64%52-week change26.42P/E (Trailing)‪12.29%‬Profit Margin
- TLTLTNASDAQiShares 20+ Year Treasury Bond ETF9.46BMarket Cap-14.37%52-week change—P/E (Trailing)—Profit Margin
- BRKRNASDAQBruker Corp.8.34BMarket Cap+30.46%52-week change74.88P/E (Trailing)‪-2.03%‬Profit Margin
- LIVNNASDAQLivaNova PLC4.27BMarket Cap+30.27%52-week change23.22P/E (Trailing)‪12.81%‬Profit Margin
Profile Summary - IART - Integra LifeSciences Holdings Corporation
About
Integra LifeSciences Holdings Corporation is a medical technology company that develops, manufactures, and markets products used in neurosurgery, regenerative medicine, and surgical reconstruction. The company’s current business is organized around two main segments, Codman Specialty Surgical and Tissue Technologies,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
